Trials / Completed
CompletedNCT02641470
The Effect of DA9301 on Tablet Computer-Induced Asthenopia
Clinical Trial to Investigate the Effect of DA9301 on Tablet Computer-induced Asthenopia in Humans
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Namyi Gu · Academic / Other
- Sex
- All
- Age
- 20 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Asthenopia or eye strain describes nonspecific symptoms of an eye when it is tired from intensive work. Vaccinium uliginosum is a flowering plant in the genus Vaccinium. This plant is native to cool temperature regions of the Northern Hemisphere. Considering its antioxidative ingredients, the extract of Vaccinium uliginosum is expected to play a significant role in treating various ocular pathologies. The investigators performed a randomized, case-controlled study in healthy subjects and investigated the protective effect of Vaccinium uliginosum extract (DA-9301) on tablet computer-induced asthenopia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | DA9301 (Vaccinium uliginosum extract) | |
| DIETARY_SUPPLEMENT | Placebo |
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2014-02-01
- First posted
- 2015-12-29
- Last updated
- 2015-12-29
Source: ClinicalTrials.gov record NCT02641470. Inclusion in this directory is not an endorsement.